Medical device giant TaiDoc Technology released its 2025 results, showcasing significant margin improvement despite a slight dip in overall revenue.

• Profitability Surge: While 2025 revenue fell 9.4% to NT$4.2 billion, gross margins climbed to 45.95%. Boosted by non-operating financial valuation gains, net profit attributable to the parent rose over 24%, resulting in an EPS of $15.12.
• Capital Allocation: The board proposed a total dividend of NT$6 (NT$5 cash, NT$1 stock).
• Treasury Stock: To support share value, TaiDoc will launch a buyback of 2,500 shares between March 12 and May 11, with a maximum budget of NT$450 million (price range of NT$92–$180). This represents approximately 2.62% of the company’s total issued shares.

Resource: 泰博去年EPS 15.12元，今起砸最多4.5億元買庫藏股2500張